DrugId:  1
1. Name:  Mocetinostat
2. Groups:  Investigational
3. Description:  Mocetinostat has been used in trials studying the treatment of Lymphoma, Urothelial Carcinoma, Relapsed and Refractory, Myelodysplastic Syndrome, and Metastatic Leiomyosarcoma, among others.
4. Indication:  Not Available
